These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8112904)

  • 21. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group.
    Richards AM; Nicholls MG; Yandle TG; Ikram H; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Frampton C; Crozier IG; Smyth DW
    Heart; 1999 Feb; 81(2):114-20. PubMed ID: 9922344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of neuroendocrine activation at rest and during exercise following acute myocardial infarction.
    Batin PD; Hawkins M; Cowley AJ
    Eur Heart J; 1994 Nov; 15(11):1552-7. PubMed ID: 7835371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B-type natriuretic peptide infusions in acute myocardial infarction.
    Hillock RJ; Frampton CM; Yandle TG; Troughton RW; Lainchbury JG; Richards AM
    Heart; 2008 May; 94(5):617-22. PubMed ID: 17639095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma levels of adrenomedullin in patients with acute myocardial infarction.
    Yoshitomi Y; Nishikimi T; Kojima S; Kuramochi M; Takishita S; Matsuoka H; Miyata A; Matsuo H; Kangawa K
    Clin Sci (Lond); 1998 Feb; 94(2):135-9. PubMed ID: 9536921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baroreflex sensitivity and neurohormonal activation in patients with acute myocardial infarction.
    Hartikainen J; Fyhrquist F; Tahvanainen K; Länsimies E; Pyörälä K
    Br Heart J; 1995 Jul; 74(1):21-6. PubMed ID: 7662448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of N-terminal pro-atrial natriuretic factor (1-98) in acute myocardial infarction: comparison with atrial natriuretic factor (99-126) and clinical evaluation.
    Omland T; Bonarjee VV; Nilsen DW; Sundsfjord JA; Lie RT; Thibault G; Dickstein K
    Br Heart J; 1993 Nov; 70(5):409-14. PubMed ID: 8260270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction.
    Soejima H; Ogawa H; Yasue H; Kaikita K; Takazoe K; Nishiyama K; Misumi K; Miyamoto S; Yoshimura M; Kugiyama K; Nakamura S; Tsuji I
    J Am Coll Cardiol; 1999 Oct; 34(4):983-8. PubMed ID: 10520779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure.
    Dickstein K; Chang P; Willenheimer R; Haunsø S; Remes J; Hall C; Kjekshus J
    J Am Coll Cardiol; 1995 Aug; 26(2):438-45. PubMed ID: 7608448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurohumoral changes in patients with left ventricular dysfunction following acute myocardial infarction and the effect of nitrate therapy: a randomized, double-blind, placebo-controlled long-term study.
    Tingberg E; Roijer A; Thilen U; Ohlin H
    J Cardiovasc Pharmacol; 2006 Oct; 48(4):166-72. PubMed ID: 17086095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions.
    Yusuf S; Pepine CJ; Garces C; Pouleur H; Salem D; Kostis J; Benedict C; Rousseau M; Bourassa M; Pitt B
    Lancet; 1992 Nov; 340(8829):1173-8. PubMed ID: 1359258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of neurohumoral systems in postinfarction left ventricular dysfunction.
    Rouleau JL; de Champlain J; Klein M; Bichet D; Moyé L; Packer M; Dagenais GR; Sussex B; Arnold JM; Sestier F
    J Am Coll Cardiol; 1993 Aug; 22(2):390-8. PubMed ID: 8101532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurohormonal activation in patients with mild or moderately severe congestive heart failure and effects of ramipril. The Ramipril Trial Study Group.
    Sigurdsson A; Amtorp O; Gundersen T; Nilsson B; Remes J; Swedberg K
    Br Heart J; 1994 Nov; 72(5):422-7. PubMed ID: 7818958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-type natriuretic peptide as a marker of the effects of enalapril in patients with heart failure.
    Yoshimura M; Mizuno Y; Nakayama M; Sakamoto T; Sugiyama S; Kawano H; Soejima H; Hirai N; Saito Y; Nakao K; Yasue H; Ogawa H
    Am J Med; 2002 Jun; 112(9):716-20. PubMed ID: 12079712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enalapril improves heart failure induced by monocrotaline without reducing pulmonary hypertension in rats: roles of preserved myocardial creatine kinase and lactate dehydrogenase isoenzymes.
    Ishikawa K; Hashimoto H; Mitani S; Toki Y; Okumura K; Ito T
    Int J Cardiol; 1995 Jan; 47(3):225-33. PubMed ID: 7721499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms involved in cardiac enlargement and congestive heart failure development after acute myocardial infarction.
    Kleber FX; Nussberger J; Niemöller L; Doering W
    Cardiology; 1992; 81(4-5):213-20. PubMed ID: 1301246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between early plasma atrial natriuretic factor levels and exercise performance after myocardial infarction.
    Omland T; Bonarjee VV; Aakvaag A; Aarsland T; Dickstein K
    Eur Heart J; 1993 Aug; 14(8):1022-6. PubMed ID: 8404931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of enalapril on myocardial noradrenaline overflow during exercise in patients with chronic heart failure.
    Mulligan IP; Fraser AG; Lewis MJ; Henderson AH
    Br Heart J; 1989 Jan; 61(1):23-8. PubMed ID: 2537095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of enalapril on tissue factor in patients with uncomplicated acute myocardial infarction.
    Soejima H; Ogawa H; Yasue H; Suefuji H; Kaikita K; Tsuji I; Kumeda K; Aoyama N
    Am J Cardiol; 1996 Aug; 78(3):336-40. PubMed ID: 8759815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II).
    Swedberg K; Held P; Kjekshus J; Rasmussen K; Rydén L; Wedel H
    N Engl J Med; 1992 Sep; 327(10):678-84. PubMed ID: 1495520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
    Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
    Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.